Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00040183
Status:
COMPLETED
Last Update Posted:
2018-01-10
First Post:
2002-06-21
Brief Title:
OSI-774 Tarceva Plus Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Sponsor:
Organization:
Astellas Pharma Inc